Table 2 Anti-ganglioside IgG antibodies in patients with Fisher syndrome overlapping Guillain–Barré syndrome (FS/GBS)
FS/GBSGBSFS
TotalVentilatedUnventilated
No of patients451134100100
IgG antibodies to:n (%)n (%)n (%)n (%)n (%)
    GT1a44 (98%)#*, #§11 (100%)33 (97%)17 (17%)78 (78%)
    GQ1b44 (98%)#†, #¶11 (100%)33 (97%)11 (11%)79 (79%)
    GM1, GM1b, GD1a, or GalNAc-GD1a7 (16%)#‡3 (27%)4 (12%)57 (57%)8 (8%)
  • *p<0.001; †p<0.001; ‡p<0.001 (between FS/GBS and GBS patients); §p = 0.005; ¶p = 0.007 (between FS/GBS and FS patients).

  • NS, not significant (p>0.05); #, significant differences between antibody-positive FS/GBS and GBS or FS patients.